A

Alto Neuroscience
D

ANRO

19.450
USD
1.22
(6.69%)
مغلق
حجم التداول
32,983
الربح لكل سهم
-2
العائد الربحي
-
P/E
-8
حجم السوق
604,240,216
المقالات

العنوان: Alto Neuroscience

القطاع: Healthcare
الصناعة: Biotechnology
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.